Future Medicine India – Cover Story, Medical Research News Cover Story Archives | Future Medicine India

Cover Story

Seropositivity higher among women

Most of the surveys conducted in India seem to indicate that seropositivity appears to be higher in women than in men.

Read More..

“Any definitive conclusion on SARS-CoV-2 immunity needs more evidence”

In an interaction with FM, Dr Lahariya points out that while serosurveys remain the best tool to fathom the level of population immunity due to past infection, it is important that the results of these studies be interpreted carefully, factoring in their context and limitations.


High infection numbers, but low in prevalence

In mid-May, when India’s centrally imposed lockdown restrictions began to ease up, the Indian Council of Medical Research (ICMR) launched a nationwide cross-sectional serosurvey in over 26,000 individuals in 70 districts.


Whither herd immunity?

They were supposed to be further proof that India is inching closer towards herd immunity against COVID-19, but the results of India’s latest serosurveys have turned out to be anything but. Serosurveillance, considered the gold standard for measuring population immunity arising out of past infection or vaccination, can provide crucial insights into progression of a […]

S Harachand

“The mental health aspect of COVID-19 is not getting its due share of attention”

In a conversation with FM, Dr Indla Ramasubba Reddy is director, VIMHANS Hospital, Vijayawada, AP, well-known for his extensive work in social psychiatry in Andhra Pradesh and recipient of multiple state government awards, discusses mental health during the COVID-19 era as well as other psycho-social aspects of the pandemic, including stigma.

The new normal

India eases stay-at-home measures even as fresh cases of COVID-19 hit new highs every day

S Harachand

Contagion engulfs Mumbai’s slums

Mumbai, the fulcrum of India’s economic activity, has been the worst-hit in the country, accounting for 20 percent of the country’s total coronavirus infections and nearly 25 percent of the deaths.